In This Section:
Obesity
Obesity
The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.
Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
Close X
Other videos you might like
Watch time: 7m 3s
Watch time: 7m 20s
Video
AHA 23 Late-Breaker Discussion: The SELECT Trial
Watch time: 21m 35s
Video
CardioNerds @AHA23: Presidential Advisory on CKM Health
Watch time: 14m 32s
Video
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial
Watch time: 13m 24s
Video
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Watch time: 13m 28s
Video
ECO 23: Impact of Obesity on Heart Failure Outcomes
Watch time: 7m 7s
Video Series
e-SPACE Cardio-Renal-Metabolic 2023
Video
Obesity Management Strategies in 2023
Watch time: 17m 7s
Recent Videos
Video
HFSA 24: The HuMAIN-HFpEF Trial
Watch time: 4m 5s
Video
EASD 24: Prespecified Analysis from the SELECT Trial
Watch time: 5m 37s
Video
Glucagon-Containing Dual and Triple Agonists For Obesity and MASH
Watch time: 8m 36s
Video
ECO 24: Long-Term Weight Loss in the SELECT trial
Watch time: 11m 42s
Video
ECO 24: Increasing GLP1-RA Efficacy by Targeting Non-coding RNA
Watch time: 4m 50s
Video
ECO 24: The STEP 10 Trial
Watch time: 8m 28s